Taro Pharmaceutical Industries (NYSE:TARO) Cut to Sell at Zacks Investment Research
Zacks Investment Research cut shares of Taro Pharmaceutical Industries (NYSE:TARO) from a hold rating to a sell rating in a report issued on Friday, Zacks.com reports. According to Zacks, “Taro Pharmaceutical Industries is engaged in the production, research and development, and marketing of prescription and over-the-counter pharmaceutical products, with a focus on generic products. In […]
Taro Pharmaceutical Industries (NYSE:TARO) Cut to Sell at Zacks Investment Research
Zacks Investment Research cut shares of Taro Pharmaceutical Industries (NYSE:TARO) from a hold rating to a sell rating in a report issued on Friday, Zacks.com reports. According to Zacks, “Taro Pharmaceutical Industries is engaged in the production, research and development, and marketing of prescription and over-the-counter pharmaceutical products, with a focus on generic products. In […]